TY - JOUR
T1 - A Pilot Randomized Control Trial of Motor-Based Treatments for Childhood Apraxia of Speech
T2 - Rapid Syllable Transition Treatment and Ultrasound Biofeedback
AU - McCabe, Patricia
AU - Preston, Jonathan L.
AU - Evans, Pippa
AU - Heard, Rob
N1 - Publisher Copyright:
© 2023 The Authors.
PY - 2023/3
Y1 - 2023/3
N2 - Purpose: Both Rapid Syllable Transition Treatment (ReST) and ultrasound biofeedback are effective approaches to treating childhood apraxia of speech (CAS). The purpose of the study was to compare outcomes from these two motor-based treatment approaches for school-age children with CAS. Method: In a single site, single blind randomized control trial, 14 children with CAS ages 6–13 years were randomly assigned to 12 sessions over 6 weeks of either of ultrasound biofeedback treatment (with a speech motor chaining practice structure) or ReST. Treatment was delivered at The University of Sydney by students trained and supervised by certified speech-language pathologists. Transcriptions from blinded assessors were used to compare the two groups on speech sound accuracy (percent phonemes correct) and prosodic severity (lexical stress errors and syllable segregation) in untreated words and sentences at three time points: pretreatment, immediately posttreatment, and 1-month posttreatment (i.e., retention). Results: Both groups showed significant improvement on treated items indicating a treatment effect. At no time was there a difference between groups. Both groups showed a significant improvement in speech sound accuracy on untreated words and sentences from pre to post and neither group showed an improvement in prosody pre–post. Changes to speech sound accuracy were retained by both groups at 1-month follow-up. Significant improvement in pro-sodic accuracy was reported at the 1-month follow-up. Conclusions: ReST and ultrasound biofeedback were equally effective. Either ReST or ultrasound biofeedback may be viable treatment options for school-age children with CAS.
AB - Purpose: Both Rapid Syllable Transition Treatment (ReST) and ultrasound biofeedback are effective approaches to treating childhood apraxia of speech (CAS). The purpose of the study was to compare outcomes from these two motor-based treatment approaches for school-age children with CAS. Method: In a single site, single blind randomized control trial, 14 children with CAS ages 6–13 years were randomly assigned to 12 sessions over 6 weeks of either of ultrasound biofeedback treatment (with a speech motor chaining practice structure) or ReST. Treatment was delivered at The University of Sydney by students trained and supervised by certified speech-language pathologists. Transcriptions from blinded assessors were used to compare the two groups on speech sound accuracy (percent phonemes correct) and prosodic severity (lexical stress errors and syllable segregation) in untreated words and sentences at three time points: pretreatment, immediately posttreatment, and 1-month posttreatment (i.e., retention). Results: Both groups showed significant improvement on treated items indicating a treatment effect. At no time was there a difference between groups. Both groups showed a significant improvement in speech sound accuracy on untreated words and sentences from pre to post and neither group showed an improvement in prosody pre–post. Changes to speech sound accuracy were retained by both groups at 1-month follow-up. Significant improvement in pro-sodic accuracy was reported at the 1-month follow-up. Conclusions: ReST and ultrasound biofeedback were equally effective. Either ReST or ultrasound biofeedback may be viable treatment options for school-age children with CAS.
UR - http://www.scopus.com/inward/record.url?scp=85150001402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150001402&partnerID=8YFLogxK
U2 - 10.1044/2022_AJSLP-22-00144
DO - 10.1044/2022_AJSLP-22-00144
M3 - Article
C2 - 36848673
AN - SCOPUS:85150001402
SN - 1058-0360
VL - 32
SP - 613
EP - 628
JO - American journal of speech-language pathology
JF - American journal of speech-language pathology
IS - 2
ER -